| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRANSPROCEED.2009.06.009 |
| P698 | PubMed publication ID | 19715883 |
| P2093 | author name string | M Batlle | |
| F Pérez-Villa | |||
| A Sionis | |||
| E Roig | |||
| M A Castel | |||
| A Lázaro | |||
| E García-Pras | |||
| I Vallejos | |||
| P2860 | cites work | Thrombospondin-1 is a major activator of TGF-beta1 in vivo | Q28513856 |
| The thrombospondin 1-TGF-beta axis in fibrotic renal disease | Q33966594 | ||
| Angiopoietin/tie-2 as mediators of angiogenesis: a role in congestive heart failure? | Q48036307 | ||
| Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure. | Q48424825 | ||
| Correlation between mast cell density and myocardial fibrosis in congestive heart failure patients. | Q50675712 | ||
| The thrombospondins | Q57919794 | ||
| Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation | Q61833411 | ||
| Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide | Q80557623 | ||
| Inflammation, endothelial dysfunction and angiogenesis markers in chronic heart failure patients | Q80865226 | ||
| Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts | Q81802458 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2231-2233 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | Transplantation Proceedings | Q7834825 |
| P1476 | title | Decreased expression of thrombospondin-1 in failing hearts may favor ventricular remodeling. | |
| P478 | volume | 41 |
| Q30618651 | Cardiac CD47 drives left ventricular heart failure through Ca2+-CaMKII-regulated induction of HDAC3. |
| Q35582221 | Changes in the myocardial interstitium and contribution to the progression of heart failure |
| Q35542423 | Matricellular proteins in cardiac adaptation and disease |
| Q37925022 | Matricellular proteins: new molecular targets to prevent heart failure |
| Q93173234 | Role of thrombospondin‑1 and thrombospondin‑2 in cardiovascular diseases (Review) |
| Q92368300 | The right ventricular fibroblast secretome drives cardiomyocyte dedifferentiation |
| Q38177946 | Thrombospondin-1 and CD47 regulation of cardiac, pulmonary and vascular responses in health and disease |
| Q36479630 | Thrombospondins in the transition from myocardial infarction to heart failure. |
| Q38052913 | Thrombospondins, potential drug targets for cardiovascular diseases |
| Q39438819 | Thrombospondins: A Role in Cardiovascular Disease |
| Q37838085 | When are pro-inflammatory cytokines SAFE in heart failure? |
Search more.